IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
Life review of elderly depression
Development and application of ATR-FTIR spectroscopy for mixture homogeneity in pharmaceutical application
The Increasing Damage in Tubular Cell of Infant Mice’s Kidneys from Carbofuran Exposure during its Mothers’ Lactation Period
Trend of transsexualism problem and its implications towards muslim community in Malaysia
Development and validation of RP-HPLC method for the estimation of pidotimod in tablet dosage form
Evaluation of neurotoxicity of the ethanolic bark extract of Holarrhena pubescens Wall. ex G.Don in mice
Design, synthesis and evaluation of 2-aminobenzimidazole derivatives: strong candidate for PPAR gamma agonists.
Prediction of Heart Disease Using Feature Selection and Random Forest Ensemble Method
Strategies for Antiviral Drugs from Plants by Targeting the Hemagglutinin, Neuraminidase and other receptors of Influenza A virus
The impact of human resource and quality management in health care: A Review
12345678910...
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Development and Evaluation of IER based Formulation of Ondansetron HCl

Author: NADIR KHAN, HARJEET SINGH, VIDHAN CHAND BALA, VIKAS ANAND SAHARAN
Abstract: Context: Ion exchange resin is a viable approach to improve the unpleasant taste of better drug, especially for patient compliance. Ondansetron HCl is a bitter antiemetic drug, used as the treatment of vomiting and nausea. The emetic patient requires quicker onset of action, there is a need to develop FDTs. FDTs overcome problems such as difficulty in swallowing. Materials and methods: In this study, taste masked complexes were prepared in various ratio such as (1:1, 1:2, 1:3 and 1:4) of Amberlite IRP69. Prepared complexes were characterized by FTIR spectroscopy, particle size, dissolution and in vitro taste evaluation. Taste masked FDTs were prepared by direct compression. Then, all tablet formulations were evaluated for hardness, disintegration time, wetting time, friability, thickness and dissolution. Results: The complexes with varying ratio of Amberlite IRP69 to Ondansetron HCl had taste masking ability. The best result of the complex was achieved for drug: IER ratio of 1:3. Taste masked Ondansetron HCl; FDTs were prepared which had good hardness 2.9- 3.3 kg/cm2. And disintegration time of 58- 43 sec. FDTs showed 87% drug release in 30 min which is required for quicker onset of action. Conclusion: IER complexes provide sufficient taste masking without reducing the release of the drug from the complexes. FDTs of ondansetron HCl were prepared by direct compression method for immediate drug release and fast disintegration.
Keyword: Taste masking, Ion exchange resin, Fast dissolving tablets, Ondansetron hydrochloride, Amberlite IRP69, Sodium Starch Glycolate.
DOI: https://doi.org/10.31838/ijpr/2020.12.04.111
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free